UPDATED 2/18/21 @ 5:05AM Organization Status Type Abell Eyes - Lexington Opening Late at 12:00PM Thursday BUSINESSES Adcolor, Inc. Opening Late at 10:00AM Today Snow Plan BUSINESSES Aging With Grace - The Health Club for Seniors Closed Thursday Operating Remotely BUSINESSES All About Kids - Lexington Delayed 2 hours Thursday DAYCARES Amazon - Winchester Opening Late at 8:00AM Today BUSINESSES Anderson County Closed Thursday Non-Traditional Instruction Day SCHOOLS Animal Hospital of Danville Closed Thursday BUSINESSES Asbury Theological Seminary Closed Through Thursday COLLEGES Asbury University Closed Through Friday 2/19Virtual Learning COLLEGES Augusta Independent Closed Thursday Non-Traditional Instruction Day SCHOOLS Aunties Academy Closed Thursday DAYCARES Baby Health Services Closed Thursday BUSINESSES Bank of the Bluegrass Delayed 1 hour Thursday BUSINESSES Barbourville Independent Closed Thursday SCHOOLS Barnhill Pediatric Dentistry Closed Thursday BUSINESSES Bath Co. Memorial L
Posted on 461
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Kenneth C. Frazier, chairman and chief executive officer, will retire as CEO, effective June 30, 2021. Mr. Frazier will continue to serve on Merck’s board of directors as executive chairman, for a transition period to be determined by the board. The Merck board of directors has unanimously elected Robert M. Davis, Merck’s current executive vice president, global services and chief financial officer, as chief executive officer, as well as a member of the board, effective July 1, 2021. Mr. Davis will become president of Merck, effective April 1, 2021, at which time the company’s operating divisions Human Health, Animal Health, Manufacturing, and Merck Research Laboratories will begin reporting to him.
Kenneth Frazier, North Philadelphia native and one of the only Black Fortune 500 CEOs, is retiring
CNNWire
PHILADELPHIA Merck CEO Kenneth Frazier, who is currently one of the few Black CEOs of a Fortune 500 company, is retiring in June, ending a nearly 30-year run with the company.
The pharmaceutical giant announced the change Thursday, naming Chief Financial Officer Robert Davis as its new leader effective July 1. Frazier has served as Merck s CEO since 2011 and had made headlines in recent years for his statements on racial justice and his public tussles with former President Donald Trump. On behalf of the entire Merck board, I thank Ken for his strong and highly principled leadership and his commitment to the company s core values of scientific excellence, business integrity, patient focus and respect for all people, said Les Brun, Merck s lead independent director, in the release.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Kenneth C. Frazier to Retire as Merck CEO; Board Elects Robert M. Davis as Successor; Frazier to Continue as Executive Chairman
February 4, 2021 GMT
KENILWORTH, N.J. (BUSINESS WIRE) Feb 4, 2021
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Kenneth C. Frazier, chairman and chief executive officer, will retire as CEO, effective June 30, 2021. Mr. Frazier will continue to serve on Merck’s board of directors as executive chairman, for a transition period to be determined by the board. The Merck board of directors has unanimously elected Robert M. Davis, Merck’s current executive vice president, global services and chief financial officer, as chief executive officer, as well as a member of the board, effective July 1, 2021. Mr. Davis will become president of Merck, effective April 1, 2021, at which time the company’s operating divisions Huma